Background: Onychomycosis is one of the most common nail diseases and constitutes up to 50% of all nail conditions. It is a chronic fungal nail infection common in the HIV-infected population. Few studies have found fungal organisms in the nail without clinical evidence, and thus, termed subclinical onychomycosis. Objectives: We analyzed the nails of the HIV population in our hospital, searching for subclinical onychomycosis. Method: A distal nail clipping was stained with PAS and observed by a trained dermatopathologist. Results: All of our samples (n = 48) turned out to be negative for fungal structures. Conclusions: The epidemiology of onychomycosis is changing, treatment options are much better now, and diagnosis and infection detection are being done earlier. Therefore, we will continue to further study this disease in other patient populations so that we can compare our results and see whether the incidence of onychomycosis in the HIV population is now similar to that in those without HIV infection of the same age.

1.
Chang
P
,
Ucelo
Z
,
del Pilar Garzaro Chávez
H
.
Onychomycosis and Immunodepression
.
Curr Fungal Infect Rep
.
2017
;
11
(
4
):
252
7
. 1936-3761
2.
Ruíz-López
P
,
Moreno-Coutiño
G
,
Fernández-Martínez
R
,
Espinoza-Hernández
J
,
Rodríguez-Zulueta
P
,
Reyes-Terán
G
.
Evaluation of improvement of onychomycosis in HIV-infected patients after initiation of combined antiretroviral therapy without antifungal treatment
.
Mycoses
.
2015
Sep
;
58
(
9
):
516
21
.
[PubMed]
0933-7407
3.
Moreno-Coutiño
G
,
Arenas
R
,
Reyes-Terán
G
.
Improvement in onychomycosis after initiation of combined antiretroviral therapy
.
Int J Dermatol
.
2013
Mar
;
52
(
3
):
311
3
.
[PubMed]
0011-9059
4.
Elbendary
A
,
El Tawdy
A
,
Zaki
N
,
Alfishawy
M
,
Rateb
A
.
Subclinical onychomycosis in patients with type II diabetes
.
Dermatol Rep
.
2015
Dec
;
7
(
3
):
6099
.
[PubMed]
2036-7392
5.
Walling
HW
.
Subclinical onychomycosis is associated with tinea pedis
.
Br J Dermatol
.
2009
Oct
;
161
(
4
):
746
9
.
[PubMed]
0007-0963
6.
Hay
RJ
,
Baran
R
.
Why should we care if onychomycosis is truly onychomycosis?
Br J Dermatol
.
2015
Feb
;
172
(
2
):
316
7
.
[PubMed]
0007-0963
7.
Shemer
A
,
Gupta
AK
,
Farhi
R
,
Daigle
D
,
Amichai
B
.
When is onychomycosis onychomycosis? A cross-sectional study of fungi in normal-appearing nails
.
Br J Dermatol
.
2015
Feb
;
172
(
2
):
380
3
.
[PubMed]
0007-0963
8.
Barak
O
,
Asarch
A
,
Horn
T
.
PAS is optimal for diagnosing onychomycosis
.
J Cutan Pathol
.
2010
Oct
;
37
(
10
):
1038
40
.
[PubMed]
0303-6987
9.
Rodwell
GE
,
Bayles
CL
,
Towersey
L
,
Aly
R
.
The prevalence of dermatophyte infection in patients infected with human immunodeficiency virus
.
Int J Dermatol
.
2008
Apr
;
47
(
4
):
339
43
.
[PubMed]
0011-9059
10.
Moreno-Coutiño
G
,
Arenas
R
,
Reyes-Terán
G
.
Clinical presentation of onychomycosis in hiv/aids: a review of 280 mexican cases
.
Indian J Dermatol
.
2011
Jan
;
56
(
1
):
120
1
.
[PubMed]
0019-5154
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.